Technology

ivabradine (Corlanor)

April 16, 2015 — The U.S....

ticagrelor, AstraZeneca, FDA, crushing, option

Ticagrelor (Brilinta) 90 mg tablets from AstraZeneca now have FDA approval to be crushed and administered in water by swallowing or via nasogastric tube.

...

Boston Scientific, Watchman LAA device, FDA approval

The Watchman left atrial appendage closure device from Boston Scientific Corp....

Xarelto, rivaroxaban, Starter Pack, FDA, deep vein thrombosis, pulmonary embolis

The Xarelto Starter Pack from Janssen Pharmaceuticals Inc....

Zontivity (vorapaxar) tablets reduce the risk of heart attack, stroke, cardiovascular death and need for procedures to restore the blood flow to the heart in patients with a previous heart attack o...

Atherotech Diagnostics Lab offers warfarin sensitivity, Plavix sensitivity and thrombophilia risk tests.

...

Merck FDA Approval Liptruzet

Liptruzet (pronounced LIP-true-zett) contains ezetimibe, an efficacious LDL cholesterol lowering therapy, and atorvastatin, currently one of the most widely prescribed statins in the United States....

April 5, 2013 — A study led by researchers at the University of North Carolina indicates a newly approved blood thinner blocks a key component of the human blood clotting system and may increase th...

AspirinWorks Test Kit

Corgenix Medical Corp. has announced that Atherotech Diagnostics Lab will carry its AspirinWorks Test for determining aspirin effect.

...

Xarelto rivaroxaban Janssen Pharmaceuticals Deep Vein Thromosis Treament

Rivaroxaban (Xarelto) is an oral anticoagulant for the treatment of deep vein thrombosis (DVT) and/or pulmonary embolism (PE), and to reduce the risk of recurrence of DVT and PE following initial t...

The U.S. Food and Drug Administration (FDA) approved the first generic version of the cholesterol-lowering drug Lipitor (atorvastatin calcium tablets).

...

Janssen Pharmaceuticals Inc. announced the U.S....

Edarbi is a once-daily oral therapy for use alone or in combination with other antihypertensive medications to treat hypertension....

Azilsartan medoxomil, also known as Edarbi, is a hypertension drug that has been shown to be more effective in lowering 24-hour blood pressure compared with two other FDA-approved hypertension drugs, ...

Dabigatran is an alternative to warfarin to help prevent dangerous blood clots in patients with atrial fibrillation, according to guidelines from the American College of Cardiology, American Heart Ass...

Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets are designed for the treatment of high blood pressure....

Eplerenone (Inspra) is a steroid nucleus-based mineralcorticoid receptor (MR) antagonist with a higher degree of selectivity than spironolactone....

Amlodipine Besylate/Benazepril is a generic equivalent to Novartis' Lotrel blood pressure medication.

...

The RE-LY study established the safety and efficacy of Pradaxa (generic: dabigatran etexilate) for stroke prevention in patients with atrial fibrillation (AFib) without INR monitoring, dose adjustment...

The first generic version of Lovenox (enoxaparin sodium injection), an anticoagulant drug used for multiple indications, including prevention of deep vein thrombosis (DVT), was cleared by the FDA in J...

A three-in-one combination drug is available for the treatment of hypertension in patients who do not respond to dual medical treatment. Daiichi Sankyo Inc....